ADVANCE infectious diseases pharmacy through collaboration, research and education and LEAD antimicrobial stewardship to OPTIMIZE the care of patients with infections in every practice setting

  • Home
  • Live CE Webinar: Microbiome Restoration: What Therapies Can I Use for My “Gut Check”?

Live CE Webinar: Microbiome Restoration: What Therapies Can I Use for My “Gut Check”?

  • 15 Jun 2023
  • 1:00 PM - 2:00 PM (EDT)

Thursday, June 15, 2023
12:00 pm – 1:00 pm CT / 1:00 pm – 2:00 pm ET


The human gastrointestinal (GI) microbiome comprises approximately 100 trillion microorganisms, including bacteria, viruses, fungi, and protozoa. Maintaining the diverse composition in the GI microbiota is crucial to patient health because disruptions in the composition can lead to a number of diseases, including colonization and infection with multi-drug resistant organisms and Clostridioides difficile infection (CDI). Historically, proactive measures to restore a diverse microbiome have been limited and challenging to access. As microbiome restoration therapies become increasingly available, it is important for healthcare providers to understand the intricacies of the microbiome and its interplay with CDI.

The goal of this two-series educational webinar program is to provide information to pharmacists and other healthcare providers on the microbiome, CDI, and microbiome restoring therapies. Each webinar will include a presentation by expert faculty, active learning engagement questions throughout, and a live question & answer session.

Target Audience:

This activity was planned to meet the educational needs of Pharmacists and other healthcare providers.

Learning Objectives:

  • Compare and contrast available microbiome therapies for the treatment of Clostridioides difficile infection (CDI)
  • Outline the role in therapy for current and future microbiome therapies in the optimal treatment of patients with CDI using available clinical data
  • Describe potential challenges and mitigation strategies for widespread use of microbiome therapies for treatment of CDI


Dana R. Bowers PharmD, BCPS, BCIDP
Clinical Assistant Professor
Washington State University College of Pharmacy and Pharmaceutical Sciences
Yakima, WA

Crystal K Hodge, PharmD, BCIDP, BCPS 
Associate Professor
University of North Texas Health Science Center System College of Pharmacy and the University of Texas Southwestern Medical Center
Fort Worth and Dallas, TX



The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0672-0000-23-011-L01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Application
Activity Fee:  Free

To receive CE credit, participants must attend the webinar, complete online a post-test with a passing score of 70% or greater and an activity evaluation. Proof of completion will be submitted to NABP CPE Monitor.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.


This webinar series is supported by an unrestricted grant from Aimmune Therapeutics, a Nestlé Health Science company and Seres Therapeutics.


In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all relevant financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following relevant financial relationships have been disclosed:

  • Dr. Bowers and Dr. Hodge have no relevant financial relationship with an ineligible company to disclose.
  • SIDP planners, staff and other individuals who are in a position to control the content of this CE activity have no relevant financial relationships with an ineligible company to disclose.


Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.

The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.


Society of Infectious Diseases Pharmacists •  PO Box 1488, Warrenville, IL 60555
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software